Search Results 81-90 of 14692 for anti-TNF drugs

  1. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Side Effects - Mayo Clinic

    Check with your doctor as soon as possible if any of the following side effects occur: Less common or rare. Bleeding in the eye or redness or swelling of ...

  2. Alzheimer's: Medicines help manage symptoms and slow decline - Mayo Clinic

    FDA-approved medicines for treating symptoms · Goals for treating symptoms · Cholinesterase inhibitors · Memantine · Medicine for agitation · Antiamyloid treatment.

  3. Infliximab-Qbtx (Intravenous Route) Description and Brand Names - Mayo Clinic

    Infliximab-qbtx injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of ...

  4. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Before Using - Mayo Clinic

    Although studies on birth defects have not been done in pregnant women after use of these medicines in the eye, ophthalmic anti-inflammatory medicines have not ...

  5. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Precautions - Mayo Clinic

    Wearing soft (hydrogel) contact lenses during treatment with diclofenac has caused severe irritation (redness and itching) in some people. Therefore, do not ...

  6. Tacrolimus (Oral Route) Description and Brand Names - Mayo Clinic

    Tacrolimus is used together with other medicines to prevent the body from rejecting a transplanted organ (eg, kidney, liver, heart, or lung). This medicine may ...

  7. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Anti-TNF agents; Corticosteroids (non-US sites only). Neurological exam free ...

  8. Baricitinib (Oral Route) Description and Brand Names - Mayo Clinic

    ... medicines (eg, tumor necrosis factor or TNF antagonist) that did not work well. Baricitinib is also used to treat coronavirus disease 2019 (COVID-19) in ...

  9. Anti-interleukin-5 therapy for severe asthma: A new therapeutic option - Mayo Clinic

    Anti-interleukin-5 therapy is approved for patients with refractory asthma with an eosinophilic phenotype. The severe asthma care team at Mayo Clinic has ...

  10. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used as a maintenance treatment for moderate to severe active Crohn's disease and ulcerative colitis after receiving an infliximab medicine given by ...